author-photo

Cecila Mur Pérez

Eli Lilly and Company

1

Papers

1

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Abemaciclib, a CDK4 and 6 inhibitor with unique pharmacological properties for breast cancer therapy.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)